Projects per year
Organization Profile
Organisation profile
With thousands of years of history, the development of Chinese medicine has made a tremendous contribution to the proliferation and prosperity of the nations of China and neighboring countries. Owing to the great breadth and profundity of its theories and proven efficacy, Chinese medicine has become a new focus of attention for scientists all over the world. Committed to both inheritance and innovation in Chinese medicine, the School of Chinese Medicine (SCM) of Hong Kong Baptist University (HKBU) makes full use of modern technologies to conduct innovative research on standardisation of Chinese medicine and integration of Chinese medicine and western medicine, and contributes to the internationalisation of Chinese medicine.
The fundamental research strength of SCM lies in the academic and research experts who comprise the largest research team of Chinese medicine in Hong Kong. Riding on the University's strategy of fostering interdisciplinary research, the experts and researchers of SCM have been conducting innovative research on the traditional discipline of Chinese medicine which aims to discover new knowledge and create novel technologies for translation and application to benefit society, and they have produced very encouraging results on this front. The faculty members of SCM have produced substantial research outputs in international scientific journals and have been granted numerous patent rights from the US, European, the People's Republic of China and Hong Kong. In the results of the Research Assessment Exercise 2014 announced by the University Grants Committee, SCM outshone other institutions in the percentage of four-star rating (world leading) in the field of Chinese medicine. Looking ahead, SCM will continue to work hard and scale new heights in the research field of innovative drug discovery, precision medicine and phenome research based on Chinese medicine.
Fingerprint
Collaborations and top research areas from the last five years
Scholars
-
P. ASTHANA, Dr
- Chinese Medicine - Teaching and Research Division - Research Assistant Professor
Person
-
Impacts of sulfur fumigation on the quality and bioactivity of Qiyao Wan
XU, J., Zhongzhen, Z., FANG, L., ZHANG, W. & CHAN, K. C.
1/12/23 → 30/11/25
Project: Research project
-
Development of Small-molecule Inhibitors Targeting Sclerostin Loop3 for Osteoporosis
3/10/23 → 26/01/25
Project: Research project
-
Dissecting the Therapeutic Role of 3A2 Antibody for the Treatment of Obesity and Type 2 Diabetes
3/10/23 → 30/04/26
Project: Research project
-
A Brief Discussion on the Specialty Development System of Chinese Medicine Practitioners in Hong Kong
Chua, K. K. & Li, M., Jun 2023, In: World Journal of Public Health. 8, 2, p. 148-152 6 p.Research output: Contribution to journal › Journal article › peer-review
Open AccessFile -
Add-on Chinese medicine for hospitalized chronic obstructive pulmonary disease (CHOP): a cohort study of hospital registry
Xu, N., Zhong, K., Yu, H., Shu, Z., Chang, K., Zheng, Q., Tian, H., Zhou, L., Wang, W., Qu, Y., Liu, B., Zhou, X., Chan, K. W. & Li, J., Jan 2023, In: Phytomedicine. 109, 12 p., 154586.Research output: Contribution to journal › Journal article › peer-review
1 Citation (Scopus) -
Add-on Rehmannia-6–Based Chinese Medicine in Type 2 Diabetes and CKD: A Multicenter Randomized Controlled Trial
Chan, K. W., Kwong, A. S. K., Tan, K. C. B., Lui, S. L., Chan, G. C. W., Ip, T. P., Yiu, W. H., Cowling, B. J., Wong Taam, V., Lao, L., Feng, Y., Lai, K. N. & Tang, S. C. W., Sept 2023, In: Clinical journal of the American Society of Nephrology : CJASN. 18, 9, p. 1163-1174 12 p.Research output: Contribution to journal › Journal article › peer-review
Prizes
Activities
-
Pharmaceutics (Journal)
Ashok IYASWAMY (Guest editor)
11 Jun 2025Activity: Publication peer-review/editorial work › Editor/reviewer for publications (incl. CDCF T61 Journal Editor)
-
Metabolites (Journal)
Hoi Leong Xavier WONG (Reviewer)
2023Activity: Publication peer-review/editorial work › Editor/reviewer for publications (incl. CDCF T61 Journal Editor)
-
Nutrients (Journal)
Hoi Leong Xavier WONG (Reviewer)
2023Activity: Publication peer-review/editorial work › Editor/reviewer for publications (incl. CDCF T61 Journal Editor)
Press/Media
-
HKBU secures Theme-based Research Scheme funding to study metabolic associated fatty liver disease with metabolomics
13/07/23
1 Media contribution
Press/Media
-
Press conference on cell entry mechanism of SARS-CoV-2 and therapeutic target for COVID-19
20/03/23
1 item of Media coverage
Press/Media
-
From Molecular Target to Aptamer Drug Discovery towards US-FDA Orphan Drug Designation
Yuanyuan YU, Ge ZHANG, Aiping LYU & Luyao WANG
19/12/22 → 20/12/22
4 Media contributions
Press/Media
Student theses
-
A delivery system specifically approaching bone resorption surfaces to facilitate therapeutic modulation of MicroRans in osteoclasts
Author: Dang, L., 29 Apr 2016Supervisor: ZHANG, G. (Supervisor)
Student thesis: Master's Thesis
File -
A Material Evidence Base for Investigating the Evolution of Chinese Medicinal Varieties and Cross-cultural Exchange
Author: Brand, E. J., 4 Sept 2017Supervisor: ZHAO, Z. (Supervisor)
Student thesis: Doctoral Thesis
File -
A mechanistic study on the anti-melanoma action of quercetin
Author: Cao, H., 18 Feb 2015Supervisor: YU, Z. (Supervisor)
Student thesis: Doctoral Thesis
File